June 3, 2011 -- Maquet Cardiovascular announced that the U.S. Food and Drug Administration (FDA) has granted the company 510(k) clearance to market its CardioRoot aortic graft in the United States. A one-piece design, aortic root graft, CardioRoot will be used by vascular and cardiovascular surgeons to surgically repair or replace diseased and damaged aortae. CardioRoot is now commercially available in the United States. CardioRoot’s design mimics the anatomy of the patient’s native aortic root, including the clinically important natural sinuses of valsalva, which supply blood to the heart’s own arteries. CardioRoot’s anatomically correct shape allows easy sewing of valve remnants or a prosthetic valve within the tube, thereby avoiding potential bleeding while shortening surgical procedure time. “The CardioRoot graft is an important option for aortic root repair. The graft wall is supple, allowing better approximation with tissue. The unique properties of the graft material provide ease of suturing and superb predictability of the final geometry,” said Marc W. Gerdisch, M.D., chief of cardiothoracic surgery at Franciscan St. Francis Heart Center in Indianapolis, and a clinical assistant professor of cardiothoracic surgery at Loyola University Medical Center. Dr. Gerdisch is the first cardiothoracic surgeon in the United States to use CardioRoot on a critically ill patient. “The improved hemostasis is an added advantage of CardioRoot for complex aortic root reconstructions, substantially contributing to a dry surgical field at the end of the surgery." For more information: www.maquet.com
If you enjoy this content, please share it with a colleague
Maquet Cardiovascular Receives 510(K) Clearance To Market Cardioroot Aortic Graft In U.S.
Related Content
March 20, 2024 — PECA Labs, a medical device company reimagining the field of vascular grafts and valves with durable ...
February 26, 2024 — Hackensack Meridian Jersey Shore University Medical Center and Hackensack University Medical Center ...
The DAIC team has learned of the passing of Alain Cribier, MD, FACC, heralded as the man who pioneered the first ...
January 29, 2024 — Despite national guidelines recommending surgical aortic valve replacement (SAVR) for patients under ...
January 11, 2024 — Paragonix Technologies, a pioneer in organ transplant solutions, is proud to announce the publication ...
December 20, 2023 — The Smidt Heart Institute at Cedars-Sinai has opened an Aortic Surveillance Clinic for the ...
December 18, 2023 — The Department of Cardiovascular Surgery at The Mount Sinai Hospital has received the highest ...
November 2, 2023 — The University of Maryland Medical Center (UMMC) released a statement on the passing of a patient ...
October 25, 2023 — Edwards Lifesciences announced new data from the PARTNER 3 trial demonstrating continued low rates of ...
October 18, 2023 — A study published in The Annals of Thoracic Surgery demonstrates outstanding long-term survival ...